
You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Your window into Astellas’ world of patient-centered and science-driven healthcare, as told by the experts who bring it to life.

This article features a real patient sharing her personal experiences and is available to the public for informational purposes only. Individual experiences may vary. It does not offer personalized medical advice or patient-specific treatment guidance. Please consult your healthcare professional for medical advice.
For many people, the road to a bladder cancer diagnosis is a long and complicated journey. Melanie Costin knows this well, having struggled with symptoms for years before receiving a formal diagnosis for what she says, in hindsight, was obviously bladder cancer. "None of the doctors had considered it, but when I got to the hospital, it was very evident that I had bladder cancer," she says

Melanie Costin
Patient Advocate and CEO
Fight Bladder Cancer

Alex Filicevas
Executive Director at World
Bladder Cancer Patient
Coalition

Caroline Morel
Patient Partnerships Lead
at Astellas
Melanie is far from alone in facing the challenges that come with getting diagnosed, undergoing treatment and finding adequate support for the disease. "While the treatment landscape is evolving, advancement in bladder cancer care has been slow, leaving patients with limited treatment options, many of which can be invasive, having a severe impact on quality of life," says Alex Filicevas, Executive Director at World Bladder Cancer Patient Coalition. As annual bladder cancer cases and deaths are projected to rise by 73% and 87%, respectively, over the next 15 years1, innovative solutions to the unmet medical needs that continue to impact people living with bladder cancer are needed now more than ever.
For years, Astellas has worked and successfully delivered advancements to the bladder cancer community, making a significant impact on patient outcomes. "We are dedicated to transforming each step of the patient journey for the better and researching additional approaches that may someday offer patients even more treatment options and improved quality of life," says Caroline Morel, Patient Partnerships Lead, Oncology at Astellas.
Melanie's path to diagnosis was marked by years of uncertainty and misdiagnosis. Initially dismissed as a urinary tract infection (UTI) and treated with antibiotics, her symptoms were later attributed to mental health rather than a physical illness.
"I remember going to my doctor and saying, 'My whole life seems to be about wanting to go to the toilet, but I am actually starting to have trouble going,'" Melanie says. "It turns out that I did not have a UTI. They decided that my brain was not sending the correct messages to my bladder."
Her symptoms persisted for years until she noticed blood in her urine, finally prompting a referral to a specialist who correctly diagnosed her with bladder cancer.
The 5-year survival rate for localized bladder cancer is currently 73%, but once it metastasizes, this rate drops to just 9%2. This underscores the need for early detection and immediate treatment. However, "Disease symptoms can resemble other conditions, such as UTIs," Alex says. As many as 57% of people with bladder cancer are given a different diagnosis before receiving the correct one3.
While the disease is more common in men, the impact on women is distinct. "Women have worse outcomes because they generally tend to be diagnosed later with more advanced disease, leaving fewer treatment options available," Alex says. Almost 45% of women undergo treatment for a UTI before getting diagnosed with bladder cancer, compared to the 15% of men4.
Before her diagnosis, Melanie had never considered that bladder cancer was a possibility. "I suppose if someone said, 'Do you think you might be able to get cancer in your bladder?' I would think, 'Well, I suppose you can get it most places,' but it was not anything that had featured in my life before, and I certainly was not being looked at as being at high risk," she says.
All these burdens are exacerbated by the lack of post-diagnosis support. "The counseling for patients ahead, during and after these treatments is not sufficient," Alex says.

A bladder cancer diagnosis brings significant emotional distress, with at least 25% of patients developing anxiety and 17% experiencing depression5. Invasive treatments and a lack of adequate support only compound this toll. "It is very, very lonely," Melanie says. "You do not have that many people wanting to support you. In fact, they do not really want to hear too much about people going to the toilet. I felt very lonely sitting there in my bathroom, trying to go to the toilet."
"Many people and caregivers may also feel 'scanxiety' — anxiety surrounding scans when testing for cancer recurrence — while urinary diversions, like stoma bags, can significantly affect not just sleep, but one's self-image, which can ultimately lead to isolation," Alex says.
For Melanie, finding support was an uphill battle until she turned to Facebook and found a small, private group. "I was really excited that there were other people," Melanie says. "I am going, 'There are others! There are others! I do not feel any better, but there are others!' It took away the loneliness."
Healthcare professionals can also help alleviate psychological distress by involving patients in treatment decision-making. As therapies evolve and regimens become more complex, open dialogue is essential. However, "Shared decision making is not taking place sufficiently," Alex says.
"I think including the patient in those discussions will reduce the anxiety," Caroline says. "Would you like to have everything laid out for you, if you had a relatively complex disease, to understand what the pros and cons of each choice are and actually feel as though your voice is listened to when those decisions are being made?"
For lasting change in bladder cancer care and outcomes, collaboration with patient communities is essential. "No single organization or entity alone can achieve as much as a partnership that aims to truly understand patient needs and deliver innovation guided by those needs," Alex says.
Astellas has long been committed to advancing bladder cancer care to address unmet medical needs and improve outcomes for patients worldwide.
"Patient insights shape how Astellas works as an organization," Caroline says. It is through collaboration with patient groups across the globe that we can get a full understanding of the existing gaps and lived experiences of patients with this disease, allowing us to build awareness, better support patient communities and deliver meaningful innovation.
Our work with patient communities comes to life in multiple ways. Having listened to common challenges that caregivers face under the strain of the disease, we designed a bladder cancer handbook in co-creation with patient organizations across multiple regions, which aimed to fill the gap in available information for this community and is available for localization across affiliates. In some regions, the You in Urology platform hosts resources on bladder, prostate and other urology cancers, designed to address common hurdles from treatment issues to lifestyle challenges, such as relationships and intimacy.
"Whether it is a more accurate diagnosis or equitable access to information, it is really ensuring that we help strengthen awareness and improve access to reliable information and support," Caroline says. Experiences like Melanie's underscore the importance of listening to patients and understanding the challenges they face throughout their journey. "By listening and learning directly from patients, we can better focus our efforts on creating and delivering greater VALUE faster for patients."
1 Miao J, Zhang T, Guo H, et al. Global burden of bladder cancer and its attributable risk factors, 1990-2019. Frontiers in Oncology. September 14, 2023. Accessed October 29, 2026. https://pubmed.ncbi.nlm.nih.gov/37712386/.
2 Bladder Cancer Survival Rates. American Cancer Society. January 18, 2023. Accessed October 29, 2026. https://www.cancer.org/cancer/types/bladder-cancer/detection-diagnosis-staging/survival-rates.html.
3 World Bladder Cancer Patient Coalition Global Patient Survey Report. World Bladder Cancer Patient Coalition. June 2023. Accessed October 29, 2026. https://worldbladdercancer.org/wp-content/uploads/2023/06/WBCPC-Patient-Survey-Report.pdf.
4 The New Faces of Bladder Cancer: Findings from the Bladder Cancer Advocacy Network's Patient and Caregiver Experience Survey. Bladder Cancer Advocacy Network (BCAN). March 2026. Accessed October 29, 2026. https://bcan.org/wp-content/uploads/2026/03/The-New-Faces-of-Bladder-Cancer-no-embargo.pdf.
5 Mohamed NE, Leung TM, Benn EK, et al. Depression and anxiety among patients treated for bladder cancer: examining clinical, demographic, and psychosocial predictors. American Journal of Clinical and Experimental Urology. October 15, 2023;11(5):401-413. Accessed October 29, 2026. https://europepmc.org/article/MED/37941645.
Bladder cancer kills when caught late – yet symptom awareness remains dangerously low.1 Despite a five-year survival rate of just 40% for those diagnosed at Stage 3,2 many people delay seeking...

This article features real patients sharing their personal experiences and is available to the public for disease awareness only. Individual experiences may vary. It does not endorse any specific...
Hearing the words "you have cancer." Supporting a loved one living with a rare disease. Navigating the world as your vision begins to fade. From diagnosis to treatment, and beyond, everyone's...